A pediatric study of Durasert three-year treatment for posterior segment uveitis.

Trial Profile

A pediatric study of Durasert three-year treatment for posterior segment uveitis.

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Posterior uveitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2017 New trial record
    • 07 Feb 2017 According to a pSivida media release, the Company is in discussions with the European regulatory authority on the final design of this trial and expects to file the application in the second quarter of calendar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top